Risk factors for spontaneously self-reported postprandial hypoglycemia after bariatric surgery

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 10, 2016, Pages 3600-3607

  Nannipieri, Monica ^a   Belligoli, Anna ^b   Guarino, Daniela ^a   Busetto, Luca ^b   Moriconi, Diego ^a   Fabris, Roberto ^b   Mari, Andrea ^d   Baldi, Simona ^a   Anselmino, Marco ^e   Foletto, Mirto ^c   Vettor, Roberto ^b   Ferrannini, Ele ^f  

^a UNIVERSITY OF PISA   (Italy)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d CNR   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE PANCREAS FUNCTION TEST; FEMALE; GASTRIC BYPASS SURGERY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN CLEARANCE; INSULIN SENSITIVITY; LAPAROSCOPIC SLEEVE GASTRECTOMY; MALE; ORAL GLUCOSE INSULIN SENSITIVITY INDEX; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; POSTPRANDIAL HYPOGLYCEMIA; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SELF REPORT; SLEEVE GASTRECTOMY; ADVERSE EFFECTS; BLOOD; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; PROGNOSIS; RISK FACTOR;

ADULT; BARIATRIC SURGERY; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPOGLYCEMIA; MALE; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RISK FACTORS; SELF REPORT;

EID: 84991672066     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1143     Document Type: Article

References (37)

1. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nesiodioblas-tosis after gastric-bypass surgery. N Engl J Med. 2005;353:249-254.
2. Lee CJ, Clark JM, Schweitzer M, et al. Prevalence of and risk factors for hypoglycemic symptoms after gastric bypass and sleeve gastrec-tomy. Obesity. 2015;23:1079-1084.
3. Papamargaritis D, Koukoulis G, Sioka E, et al. Dumping symptoms and incidence of hypoglycaemia after provocation test at 6 and 12 months after laparoscopic sleeve gastrectomy. Obes Surg. 2012;22: 1600-1606.
4. Roslin MS, Dudiy Y, Brownlee A, Weiskopf J, Shah P. Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch. Surg Endosc. 2014;28:91-99.
5. Ukleja A. Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract. 2005;20:517-525.
6. Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglyco-penia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007;92:4678-4685.
7. Salehi M, Prigeon RL, D'Alessio DA. Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes. 2011;60:2308-2314.
8. Miholic J, Orskov C, Holst JJ, Kotzerke J, Pichlmayr R. Postprandial release of glucagon-like peptide-1, pancreatic glucagon, and insulin after esophageal resection. Digestion. 1993;54:73-78.
9. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulino-tropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond). 2010;34:462-471.
10. Rodieux F, Giusti V, D'Alessio DA, Suter M, Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity. 2008;16:298-305.
11. Romero L, Nicolau J, Flores L, et al. Comparable early changes in gastrointestinal hormones after sleeve gastrectomy and Roux-En-Y gastric bypass surgery for morbidly obese type 2 diabetic subjects. Surg Endosc. 2012;26:2231-2239.
12. Patti ME, McMahon G, Mun EC, et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabe-tologia. 2005;48:2236-2240.
13. Li Z, Zhang HY, Lv LX, et al. Roux-en-Y gastric bypass promotes expression of PDX-1 and regeneration of β-cells in Goto-Kakizaki rats. World J Gastroenterol. 2010;16:2244-2251.
14. Abrahamsson N, Engstrom BE, Sundbom M, Karlsson FA. GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: a potential new indication? Eur J Endocrinol. 2013;169:885-889.
15. Salehi M, Woods SC, D'Alessio DA. Gastric bypass alters both glu-cose-dependent and glucose-independent regulation of islet hormone secretion. Obesity. 2015;23:2046-2052.
16. Reubi JC, Perren A, Rehmann R, et al. Vasoreactivity is rapidly improved in obese subjects after gastric bypass surgery. Int J Obesity. 2009;33:1390-1395.
17. Chow E, Bernjak A, Williams S, et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes. 2014;63:1738-1747.
18. Driesen NR, Goldberg PA, Anderson AW, et al. Hypoglycemia reduces the blood-oxygenation level dependent signal in primary auditory and visual cortex: a functional magnetic resonance imaging study. J Neurosci Res. 2007;85:575-582.
19. Anderson AW, Heptulla RA, Driesen N, et al. Effects of hypoglycemia on human brain activation measured with fMRI. Magn Reson Imaging. 2006;24:693-697.
20. Nannipieri M, Baldi S, Mari A, et al. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab. 2013;8:4391-4399.
21. Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Fer-rannini E. Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab. 2002;283:E1159-E1166.
22. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001;24:539-548.
23. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41:368-377.
24. Ferrannini E, Natali A, Muscelli E, et al. RISC Investigators. Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia. 2011;54:1507-1516.
25. Camastra S, Muscelli E, Gastaldelli A, et al. Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients. Diabetes. 2013;62:3709-3717.
26. Marathe CS, Horowitz M, Trahair LG, et al. Relationships of early and late glycemic responses with gastric emptying during an oral glucose tolerance test. J Clin Endocrinol Metab. 2015;100:3565-3571.
27. Patti ME, Goldfine A. Hypoglycemia after gastric bypass: the dark side of GLP-1. Gastroenterology. 2014;146:605-608.
28. Salehi M, Gastaldelli A, D'Alessio DA. Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. Gastroenterology. 2014;146:669-680.
29. Marathe CS, Rayner CK, Bound M, et al. Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes. Diabetes. 2014;63:2668-2675.
30. DeFronzo RA, Hendler R, Christensen N. Stimulation of counter-regulatory hormonal responses in diabetic man by a fall in glucose concentration. Diabetes. 1980;29:125-131.
31. Kapoor RR, James C, Hussain K. Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nat Clin Pract Endocrinol Metab. 2009;5:101-112.
32. Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009;94:1069-1073.
33. Hirata Y, Uchigata Y. Insulin autoimmune syndrome in Japan. Diabetes Res Clin Pract. 1994;24(suppl 1):S153-S157.
34. Kahn CR, Flier JS, Bar RS, et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. NEngl J Med. 1976;294:739-745.
35. Taylor SI, Grunberger G, Marcus-Samuels B, et al. Hypoglycemia associated with antibodies to the insulin receptor. N Engl J Med. 1982;307:1422-1426.
36. Glaser B, Kesavan P, Heyman M, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med. 1998; 338:226-230.
37. Otonkoski T, Jiao H, Kaminen-Ahola N, et al. Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxy-late transporter 1 in pancreatic β cells. Am J Hum Genet. 2007;81: 467-474.